宿主转录组来源的HPV癌基因E6*影响评分与头颈癌致癌通路、肿瘤大小及生存显著相关
该研究分析68例HPV16阳性头颈鳞癌的RNA-seq数据,探究E6+E7表达及全长E6百分比(E6%FL)相关宿主基因与通路,发现E6%FL影响线粒体过程,其影响评分与总生存和肿瘤大小显著相关,E6向E6*转换促进氧化磷酸化、增大肿瘤并恶化预后。
要点
- E6%FL影响评分与HPV阳性HNSCC患者总生存和肿瘤大小显著相关。
- E6E7表达重现已知致癌通路并揭示额外通路,E6%FL影响线粒体过程。
- E6向E6*转换促进氧化磷酸化,可能作为HPV阳性HNSCC预后因子。
核心结论
- HPV E6E7和E6*导致广泛、剂量依赖的代偿效应及关键癌症通路失调。
- E6向E6*转换促进氧化磷酸化、增大肿瘤尺寸并恶化预后,可能作为HPV阳性HNSCC的预后因子。
研究设计与样本
- 分析68例HPV16阳性HNSCC肿瘤的RNA-seq数据,计算E6E7和E6%FL影响评分并与临床变量关联。
主要发现
- E6E7重现所有主要已知受影响通路并揭示额外通路。
- E6%FL影响线粒体过程。
- E6%FL影响评分与总生存和肿瘤大小显著相关。
关键数值与推荐
- E6%FL影响评分与总生存和肿瘤大小显著相关(具体数值未报告)。
临床怎么用
- E6%FL影响评分可能作为HPV阳性HNSCC的预后因子,辅助风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papillomavirus (HPV) oncogenes E6, E7, and shorter isoforms of E6 (E6*) are known carcinogenic factors in head and neck squamous cell carcinoma (HNSCC). Little is known regarding E6* functions. METHODS: We analyzed RNA-seq data from 68 HNSCC HPV type 16-positive tumors to determine host genes and pathways associated with E6+E7 expression (E6E7) or the percent of full-length E6 (E6%FL). Influence scores of E6E7 and E6%FL were used to test for associations with clinical variables. RESULTS: For E6E7, we recapitulated all major known affected pathways and revealed additional pathways. E6%FL was found to affect mitochondrial processes, and E6%FL influence score was significantly associated with overall survival and tumor size. CONCLUSIONS: HPV E6E7 and E6* result in extensive, dose-dependent compensatory effects and dysregulation of key cancer pathways. The switch from E6 to E6* promotes oxidative phosphorylation, larger tumor size, and worse prognosis, potentially serving as a prognostic factor for HPV-positive HNSCC.
引用
- Qin T, Koneva LA, Liu Y, et al. Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer. Head Neck. 2020. PMID: 32406560. doi:10.1002/hed.26244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。